In brief: Burns joins Progen; Cryptome appoints CSO
Monday, 23 August, 2004
Progen Industries (ASX: PGL, NASDAQ: PGLAF), announced today it had appointed former Bresagen chief financial officer and company secretary, Linton Burns, as CFO and company secretary.
Burns succeeds Milton McColl, has been Progen's CFO since late 2001.
And Melbourne-based Cryptome Pharmaceuticals (ASX: CRP) has appointed Dr Leodevico Ilag as chief scientific officer. Dr Ilag is the co-founder, former managing director and current chief technology officer of Munich proteomics company Xerion Pharmaceuticals. He is due to join Cryptome in September 2004.
Epilepsy disease model treated in a laboratory dish
A research team has used an epilepsy-like disease model in a laboratory dish to demonstrate that...
Newborns have elevated levels of an Alzheimer's biomarker
What do the brains of newborns and patients with Alzheimer's disease have in common? Both...
Cannabis use may double risk of cardiovascular disease death
Cannabis users have a 29% higher risk of acute coronary syndrome, a 20% higher risk of stroke,...
